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Abstract
Aims/hypothesis Cardiovascular disease (CVD) is the most
common cause of premature death and disability among pa-
tients with type 1 diabetes. Diabetic nephropathy accounts for
the increased cardiovascular morbidity and mortality of these
patients. We recently showed that the intensity of exercise
predicts the incidence and progression of diabetic nephropa-
thy in patients with type 1 diabetes. Little is known about the
relationship between physical activity and CVD. Therefore,
we studied how physical activity affects the risk of CVD
events in patients with type 1 diabetes.
Methods A 10 year follow-up study including 2180 type 1
diabetes patients from the nationwide multicentre Finnish
Diabetic Nephropathy Study (FinnDiane). Leisure time phys-
ical activity (LTPA) was assessed by a previously validated
self-report questionnaire. A CVD event was defined as a ver-
ified myocardial infarction, coronary procedure or stroke.
Patients were analysed separately for the risk of developing
a first ever CVD event and for the risk of a recurrent CVD
event following a baseline event.
Results A total of 206 patients had an incident CVD event
during follow-up. A higher total LTPA and higher intensity,
frequency and duration of activity were associated with a low-
er risk of incident CVD events. The observed association be-
tween exercise frequency and incident CVD remained signif-
icant when adjusted for classic risk factors. Exercise intensity
also had a borderline effect on the recurrence-free time in
patients with a major CVD event at baseline.
Conclusions/interpretation This study suggests that exercise,
particularly high frequency and high intensity exercise, may
reduce the risk of CVD events in patients with type 1 diabetes.
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Introduction
Cardiovascular disease (CVD) is the most common cause of
premature morbidity and mortality among patients with type 1
diabetes [1]. Physical activity reduces the risk of CVD in the
general population and in individuals with type 2 diabetes.
The beneficial effect of physical activity on cardiovascular
risk factors in type 1 diabetes suggests that exercise may also
reduce CVD events in these patients.
However, little is known about a potential causal relation-
ship between physical activity and CVD in type 1 diabetes. In
a cross-sectional setting, the presence of diabetic complica-
tions was associated with reduced physical activity [2, 3].
The Pittsburgh IDDMMorbidity and Mortality study demon-
strated that physical activity was longitudinally associated
with a reduced risk of CVD and premature mortality in male
but not in female patients with type 1 diabetes [4]. On the
other hand, the EURODIAB study recently demonstrated a
borderline inverse association between physical activity and
both all-cause mortality (for both sexes) and incident CVD
(women only) in patients with type 1 diabetes [5].
Diabetic nephropathy was demonstrated to account for the
increased CVD morbidity and mortality in type 1 diabetes [6].
We recently reported that the intensity of physical activity might
have an impact on the incidence and progression of diabetic
nephropathy [7]. In addition, an increasing body of evidence
suggests that the complications of type 1 diabetes, namely
CVD and diabetic nephropathy, share risk factors and develop
in parallel [8].
Therefore, the aim of this study was to assess how physical
activity may affect the risk of incident CVD in patients with
type 1 diabetes. We prospectively investigated the relationship
between baseline leisure time physical activity (LTPA) and the
development of a first ever CVD event during a 10 year follow-
up. We also analysed separately the relationship between phys-
ical activity and recurrence-free time from the baseline visit in a
group of patients with a previous CVD event at baseline.
Methods
This paper presents the results of a longitudinal study including
2180 patients with type 1 diabetes who are participating in the
ongoing nationwide, prospective, multicentre Finnish Diabetic
Nephropathy Study (FinnDiane) that aims to identify clinical,
biochemical, genetic and environmental risk factors for diabetic
complications. Type 1 diabetes was defined as onset of diabetes
before the age of 40 years and with insulin treatment initiated
within 1 year of diagnosis. Patients with end-stage renal disease
(ESRD) and patients with unknown renal status at baseline were
excluded from this analysis (n=245). No patients were exclud-
ed because of missing data on confounders. Altogether, 2074
patients had no major CVD events at baseline. Patients with
major CVD events at baseline were analysed separately for
the risk of developing an acute CVD event on top of a baseline
CVD event (n=106). The LTPA questionnaire was introduced
to the FinnDiane Study at the beginning of the year 2000;
consequently, baseline visits took place from 2000 to 2011.
Only patients with complete data on LTPAwere included.
The study protocol was approved by the ethics committees
of all participating centres. Written informed consent was ob-
tained from each patient prior to participation, and the study
was performed in accordance with the Declaration of Helsinki.
LTPA questionnaire LTPA was assessed by a self-report
questionnaire. The validity and reproducibility of the ques-
tionnaire has previously been assessed and described in detail
[9–11]. Patients were grouped according to their total LTPA
(metabolic equivalent of task [MET]h/week) into sedentary
(<10 METh/week), moderately active (10–40 METh/week)
and active (>40 METh/week). The components of LTPA (in-
tensity, frequency and duration) were also assessed. Intensity
was classified as follows: (1) low intensity, with no shortness of
breath and no sweating; (2) moderate intensity, with a moderate
degree of shortness of breath and sweating; and (3) high inten-
sity, with severe shortness of breath and profuse sweating.
Exercise frequency was classified as <1, 1–2 or >2 sessions/
week and exercise duration as ≤30, 31–60 or >60 min/session.
Clinical questionnaire At baseline, data on medication and
diabetic complications were collected via a standardised ques-
tionnaire and a thorough clinical investigation, which was com-
pleted by the attending physician. A CVD event was defined as
a clinically verified myocardial infarction (ICD-8/9 410–412,
ICD-10 I21–I23), coronary procedure (bypass grafting surgery
or angioplasty based on the Nordic Classifications of Surgical
Procedures) or either an ischaemic or haemorrhagic stroke
(ICD-8/9 430–434, ICD-10 I60–I64). Follow-up events of
CVD were identified from the Care Register for Health Care
(HILMO) and the Finnish Causes of Death Registry and were
verified from the medical records. The date of the first CVD
event was defined as the date of hospital admission due to
CVD. The reliability of these registries was found to be excel-
lent for CVD [12]. Follow-up continued until the end of 2013.
Renal status Renal status was defined based on the urinary
AER in either a timed overnight or 24 h urine collection in at
least two out of three consecutive measurements. Renal status
was categorised as follows: normal AER, <20 μg/min or
<30 mg/24 h (n = 1554); microalbuminuria, ≥20 and
<200 μg/min or ≥30 and <300 mg/24 h (n = 295); or
macroalbuminuria, ≥200 μg/min or ≥300 mg/24 h (n=225).
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ESRD was defined as ongoing dialysis or a previous kidney
transplant. BP was measured twice in the sitting position with
2 min intervals after a 10 min rest; the average of these mea-
surements was used in the analysis. Anthropometric data were
recorded and fasting blood samples were drawn for HbA1c,
lipid profile and serum creatinine determinations. Smoking
was assessed via a standardised questionnaire.
Statistical analyses
Data are presented as means±SD, median and interquartile
range (IQR), and percentages. ANOVA was used for normally
distributed variables and the Kruskal–Wallis test was used for
non-normally distributed variables. For categorical variables, the
χ2 test was used. Follow-up started from the baseline visit
(2000–2011) and person-years at risk were calculated until the
first CVD event, death or the end of 2013. The association be-
tween different LTPA components and CVD risk was studied
using Cox proportional hazard regression analyses. As the effect
of LTPA and its components could be different in patients with
or without diabetic nephropathy, we tested the interaction be-
tween different LTPA components and diabetic nephropathy be-
fore performing the multivariable analyses. Similarly, the inter-
action between LTPA and sex was tested. No component
showed any significant interaction with diabetic nephropathy
or sex (data not shown), suggesting that the association between
LTPA or its components with incident CVD could be analysed
by pooling all individuals together irrespective of kidney status
or sex. In the multivariable analyses (Table 3), model 1 repre-
sents univariate analyses including only the LTPA component. In
model 2, the static confounders, kidney status, sex, duration of
diabetes and age at onset of diabetes were entered into themodel.
The final multivariable analyses (models 3–7) were conducted
by adjusting for well-defined key risk factors for CVD: HbA1c,
systolic BP, triacylglycerol level, smoking and BMI. The highest
category for each LTPA component was used as a reference
group in all analyses and the results are presented as HRs with
95% CIs. Proportionality assumption was checked by testing
time–covariate interactions and plotting Schoenfeld residuals.
As all proportionality assumptions held, the interaction term
was not included in the models. The Kaplan–Meier method
was used to estimate the cumulative incidence of CVD and the
logrank test was used to test for between-group differences. A p
value of <0.05 was considered statistically significant. Statistical
analyses were performed using the SPSS statistical software
(version 22.2. IBM, Armonk, NY, USA).
Results
Of the eligible 2074 patients without prevalent CVD events,
47.2% were men, the mean age was 38.8±12.4 years, the
duration of diabetes 21.7 ± 12.4 years, systolic BP 133
±17 mmHg, BMI 25.2±3.6 kg/m2, and HbA1c 8.3± 1.4%
(67±15 mmol/mol). The median LTPA was 17.3 (95% CI
6.2, 33.4) METh. Regarding renal status, 74.9% of patients
had normal AER at baseline.
Table 1 presents associations between baseline clinical char-
acteristics and LTPA. Physical inactivity was associated with
smoking, BP, sex, BMI, and triacylglycerol, HbA1c and HDL-
cholesterol levels, but not with age or duration of diabetes.
Electronic supplementary material (ESM) Tables 1–3 describe
the relationship between intensity (ESM Table 1), frequency
(ESM Table 2) and duration (ESM Table 3) of LTPA and base-
line clinical variables. In general, the same baseline clinical
characteristics associated with total LTPAwere also associated
with exercise intensity, frequency and duration.
Associations between baseline characteristics and incident
CVD are summarised in ESM Table 4. During a mean follow-
up of 10.3±3.4 years, 206 (9.9%) patients had an incident
CVD event. Patients who had a CVD event were older and
heavier; had higher systolic BP, a history of smoking, a worse
lipid profile and worse glycaemic control; and used antihyper-
tensive drugs more frequently. No significant differences in
sex or diastolic BP were observed.
Patients that developed a first ever CVD event during
follow-up had lower total LTPA (21.9 [IQR 2.6–30.2] vs 24.3
[IQR 6.9–33.9; p=0.042]) compared with patients who did
not. Associations between the 10 year cumulative incidence
of first ever CVD event and the different aspects of LTPA (total
LTPA and intensity, duration and frequency of LTPA) are pre-
sented in Table 2. In general, the incidence of CVD increased
with decreasing amounts of exercise irrespective of which com-
ponent was studied. Total LTPA (p=0.028), exercise intensity
(p<0.001), exercise duration (p=0.014) and exercise frequen-
cy (p<0.001) were all associated with incident CVD.
Table 3 presents the multivariable analyses of the effect of
LTPA and intensity, duration and frequency of exercise on the
risk of an incident CVD event. A higher total LTPA and longer
duration, higher intensity and higher frequency of LTPA baseline
were associated with a lower risk of newCVD events (model 1).
Next, we added the static confounders (duration of diabetes, age
at onset of diabetes, diabetic nephropathy and sex) to the multi-
variable analysis. The findings with respect to total LTPA and
exercise intensity and frequency were unaffected by the static
confounders (model 2). However, the effect of exercise duration
on incident CVD events decreased to a non-significant level. In
models 3–7 the confounding factors (triacylglycerol, BMI, sys-
tolic BP, HbA1c and smoking) were added sequentially; higher
exercise frequency remained associated with a lower risk of
CVD events in model 7. The effect of LTPA intensity was slight-
ly reduced to become non-significant in model 6. Total LTPA
was not associated with incident CVD after taking dynamic
confounders into account (models 3–7). These confounding fac-
tors are themselves potentially affected by exercise. Although the
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interaction was not significant, we repeated this analysis in men
and women separately. In men, both intensity (moderate vs high;
borderline; HR 1.99 [95%CI 0.99, 3.98]) and frequency (low vs
high; HR 1.95 [95% CI 1.20, 3.16]) of LTPA predicted incident
CVD in the full model 7. In contrast, total LTPA (METh/week)
and exercise duration seemed to be more important in women,
but the effect was reduced when adjusted for the dynamic
confounders (model 7). These results are presented in the ESM
Tables 5 and 6.
We also analysed the relationship between LTPA and the risk
of a recurrent CVD event in a small group of patients who had
suffered a major CVD event before baseline (n=106). Of these
patients, 65% were men, the mean age was 53.7±9.0 years, the
mean duration of diabetes was 35.7±10.6 years, mean BMIwas
26.5±4.2 kg/m2, the mean systolic BP was 145±22mmHg and
mean HbA1c was 8.5±1.3% (69±14 mmol/mol). Fifty-six pa-
tients developed a new CVD event during follow-up. As shown
in Fig. 1, the intensity of exercise had an effect on the recurrence-
free time after a major CVD event at baseline (p=0.015). The
10 year cumulative risk of a recurrent CVD event was 68.5%
(95%CI, 63.4, 72.9%) in the low intensity group and 45% (95%
CI 36.3, 52.5%) in the moderate intensity group, while in the
high intensity group (n=2) there were no events during follow-
up. When adjusted for sex, diabetic nephropathy, age at onset of
diabetes and the duration of diabetes, low vs moderate/high ex-
ercise intensity was still associatedwith recurrent CVD (HR1.81
[95% CI 1.04, 3.16]). When adjusted for the other dynamic
confounders (HbA1c, systolic BP, smoking, triacylglycerol and
Table 1 Clinical characteristics
of patient groups with different
levels of total LTPA
Characteristic Sedentary Moderately active Active p value
n 689 1005 380
Male (%) 52.1 43.9 46.8 0.004
Age (years) 39.2 ± 12.6 38.7 ± 12.1 38.2 ± 12.5 0.488
Duration of diabetes (years) 22.1 ± 12.7 21.5 ± 12.1 21.7 ± 12.5 0.691
BMI (kg/m2) 25.5 ± 3.8 25.1 ± 3.6 24.8 ± 3.1 0.013
WHR
Men 0.92± 0.07 0.91 ± 0.07 0.90 ± 0.06 <0.001
Women 0.83± 0.07 0.82 ± 0.06 0.82 ± 0.07 0.091
BP (mmHg)
Systolic 135 ± 18 133 ± 17 133 ± 16 0.022
Diastolic 79± 10 79± 9 79 ± 9 0.299
HbA1c (%) 8.5 ± 1.4 8.2 ± 1.4 8.2 ± 1.4 <0.001
HbA1c (mmol/mol) 69 ± 15 66± 15 66 ± 15 <0.001
Cholesterol (mmol/l)
Total 4.84 ± 0.85 4.86 ± 0.86 4.81 ± 0.87 0.669
HDL-cholesterol 1.41 ± 0.40 1.46 ± 0.40 1.46 ± 0.43 0.024
LDL-cholesterol 2.89 ± 0.77 2.91 ± 0.79 2.85 ± 0.80 0.420
Triacylglycerol (mmol/l) 1.04 (0.78–1.46) 0.93 (0.73–1.28) 0.95 (0.72–1.28) <0.001
AHT (%) 38.1 30.2 31.2 0.002
Beta-blockers (%) 9.9 6.9 3.7 <0.001
Ever-smokers (%) 53.6 39.4 41.2 <0.001
Low exercise intensity (%) 43.3 18.6 5.1 <0.001
Low exercise duration (%) 32.1 13.8 8.4 <0.001
Low exercise frequency (%) 30.3 8.7 2.9 <0.001
Data are means ± SD, median (IQR) or percentages
AHT, antihypertensive medication
Table 2 The 10 year cumulative
incidence rates for a first CVD
event by LTPA and by intensity,
frequency and duration of
exercise
Level LTPA Intensity Frequency Duration
Low (%) 11.3 (11.0, 15.4) 15.2 (12.2, 18.1) 14.9 (11.2, 18.5) 12.6 (9.5, 15.6)
Moderate (%) 9.6 (7.8, 11.4) 9.2 (7.6, 10.8) 10.9 (5.9, 15.7) 9.6 (7.8, 11.4)
High (%) 5.6 (3.2, 7.8) 3.3 (1.6, 5.0) 8.3 (7.0, 9.5) 7.1 (5.1, 9.1)
p value 0.028 <0.001 <0.001 0.014
Data are incidence rate (95% CI)
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BMI), the effect decreased to a non-significant level. Total
LTPA, exercise frequency and exercise duration had no effect
on recurrent CVD events (data not shown).
Discussion
This prospective study showed that higher LTPA, in particular
the frequency and intensity of LTPA, is associated with a
decreased risk of incident CVD events in patients with type
1 diabetes. To our knowledge, this is the first time that not only
the total LTPA but also its components (intensity, duration and
frequency) have been explored as risk factors for incident
CVD in patients with type 1 diabetes. In a separate analysis,
exercise intensity also had a borderline effect on recurrence-
free time in patients with a major CVD event at baseline.
We previously showed that the intensity of exercise, rather
than the total amount of LTPA, predicts the progression and
development of diabetic nephropathy in type 1 diabetes [7].
We have also shown that lower intensity is associated with
prevalent CVD in a cross-sectional setting [2]. Therefore,
the results of this study confirm and extend our previous
Table 3 Cox regression
models showing HRs for
low and moderate vs
high LTPA, intensity,
frequency and duration
for an incident CVD
event
LTPA Intensity Frequency Duration
Model 1 n= 2074, 206 events n = 2030, 199 events n= 2055, 206 events n= 2074, 206 events
High 1.00 1.00 1.00 1.00
Moderate 1.41 (0.92, 2.14) 2.58 (1.55, 4.31) 1.17 (0.69, 2.00) 1.27 (0.91, 1.78)
Low 1.77 (1.15, 2.72) 4.51 (2.67, 7.63) 1.91 (1.37, 2.64) 1.76 (1.20, 2.60)
Model 2 n= 2074, 206 events n = 2030, 199 events n= 2055, 206 events n= 2074, 206 events
High 1.00 1.00 1.00 1.00
Moderate 1.51 (0.99, 2.30) 1.49 (0.88, 2.53) 1.56 (0.91, 2.66) 1.17 (0.84, 1.64)
Low 1.59 (1.03, 2.44) 1.91 (1.11, 3.28) 1.94 (1.39, 2.71) 1.37 (0.93, 2.02)
Model 3 n= 2071, 206 events n = 2027, 199 events n= 2052, 206 events n= 2071, 206 events
High 1.00 1.00 1.00 1.00
Moderate 1.50 (0.98, 2.28) 1.45 (0.86, 2.45) 1.52 (0.89, 2.61) 1.16 (0.83, 1.63)
Low 1.51 (0.98, 2.33) 1.77 (1.03, 3.07) 1.84 (1.31, 2.59) 1.29 (0.87, 2.91)
Model 4 n= 2062, 206 events n = 2018, 199 events n= 2043, 206 events n= 2062, 206 events
High 1.00 1.00 1.00 1.00
Moderate 1.50 (0.98, 2.28) 1.46 (0.86, 2.47) 1.52 (0.89, 2.61) 1.16 (0.83, 1.63)
Low 1.51 (0.98, 2.33) 1.81 (1.04, 3.12) 1.85 (1.32, 2.60) 1.30 (0.87, 1.92)
Model 5 n= 2052, 206 events n = 2008, 199 events n= 2033, 206 events n= 2052, 206 events
High 1.00 1.00 1.00 1.00
Moderate 1.50 (0.98, 2.28) 1.47 (0.87, 2.50) 1.48 (0.87, 2.54) 1.21 (0.86, 1.69)
Low 1.49 (0.97, 2.31) 1.83 (1.06, 3.17) 1.78 (1.27, 2.51) 1.30 (0.87, 1.92)
Model 6 n= 2014, 205 events n = 1971, 198 events n= 1995, 205 events n= 2014, 205 events
High 1.00 1.00 1.00 1.00
Moderate 1.42 (0.93, 2.17) 1.41 (0.83, 2.40) 1.41 (0.82, 2.42) 1.20 (0.86, 1.69)
Low 1.38 (0.89, 2.13) 1.68 (0.97, 2.92) 1.66 (1.18, 2.34) 1.26 (0.85, 1.87)
Model 7 n= 1944, 200 events n = 1901, 193 events n= 1925, 200 events n= 1944, 200 events
High 1.00 1.00 1.00 1.00
Moderate 1.36 (0.89, 2.08) 1.32 (0.78, 2.23) 1.44 (0.84, 2.46) 1.22 (0.87, 1.72)
Low 1.32 (0.85, 2.04) 1.53 (0.88, 2.68) 1.69 (1.18, 2.42) 1.25 (0.84, 1.86)
Data are HR (95% CI)
Model 1: univariate analysis including the exercise component (total LTPA and intensity, duration or frequency of LTPA)
and incident CVD
Model 2: Model 1 + sex, duration of diabetes, age at onset of diabetes, diabetic nephropathy
Model 3: Model 2 + triacylglycerol
Model 4: Model 3 + BMI
Model 5: Model 4 + systolic BP
Model 6: Model 5 + HbA1c
Model 7: Model 6 + history of smoking
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cross-sectional and longitudinal findings. Our findings are al-
so consistent with recent studies regarding the intensity of
exercise. It is well known that long-term aerobic exercise
has cardioprotective benefits. Interestingly, if the total energy
expenditure of the exercise is kept constant, then high inten-
sity exercise appears to be more cardioprotective compared
with exercise of moderate intensity [13–19]. Furthermore, pre-
vious studies indicate that the intensity of LTPA is more im-
portant than the total energy expenditure in preventing hyper-
tension and CHD and avoiding premature mortality [15, 18,
20, 21].
Based on our recent findings in diabetic nephropathy, we
expected intensity to play the most important role in CVD
prevention. In this study, however, exercise frequency (>2
sessions/week) appeared the strongest determinant of the risk
of incident CVD. This finding is in line with the current ADA
exercise recommendations for diabetes of moderate to vigor-
ous aerobic exercise for a minimum of 150 min/week (and
spreading the activity over at least 3 days during the week)
or for 30 min at least 5 days a week. ADA also recommends
not taking more than a 2-day break without exercise. On the
other hand, the exercise recommendations for type 1 diabetes
are mainly based on findings in the general population or in
patients with type 2 diabetes. Thus, further studies are war-
ranted to explore the exact mechanisms of LTPA-mediated
cardioprotection and to comprehensively evaluate the poten-
tial benefits and drawbacks of high intensity or frequent exer-
cise on CVD prevention in patients with type 1 diabetes. The
mechanisms may be distinct from those responsible for the
more modest benefits of classic time-consuming endurance
training.
Regarding cardiovascular risk factors in patients with type
1 diabetes, exercise has been shown to improve lipid levels,
insulin sensitivity and endothelial function [22]. In the general
population, physical activity has been shown to improve BP,
endothelial function, inflammation, sympathetic load, lipid
levels, obesity, HbA1c levels and insulin sensitivity. These
factors have all been implicated in the pathogenesis of diabetic
complications. Therefore, we expected in the multivariable
analyses that the potential confounding factors (HbA1c, sys-
tolic BP, triacylglycerol, BMI, smoking) would decrease the
association with LTPA intensity and frequency to a non-
significant level. Surprisingly, the association between high
exercise frequency and incident CVD events was unaffected
by the dynamic confounders. Therefore, our observation sug-
gests that frequent exercise has effects in addition to those of
traditional risk factors.
Previous prospective data on physical activity and CVD in
type 1 diabetes are limited. In the Pittsburgh Insulin-Dependent
Diabetes Mellitus Morbidity and Mortality study, an inverse
association between exercise and mortality and a weak inverse
association between participation in sports during high school
and prevalent CVDwas observed, but only inmen [4]. A recent
paper from the EURODIAB study found evidence of a mar-
ginally inverse association between exercise and all-cause mor-
tality in both sexes and evidence for a borderline inverse asso-
ciation between exercise and incident CVD in women only [5].
In these studies, however, only the total amount of exercise was
analysed, which may explain why the beneficial effects of ex-
ercise on CVD were not found in both sexes or why the asso-
ciation was only of borderline significance.
The strengths of this study were the large number of pa-
tients, the prospective study design and the use of a detailed
physical activity questionnaire which was previously validat-
ed in the Finnish population. The questionnaire is representa-
tive (12 month LTPA correlated with maximum oxygen up-
take) and has been shown to have small intraindividual vari-
ability [10]. In addition, the reliability of the hospital discharge
registry, which was used to identify the CVD events, has been
found to be appropriate for this purpose [12].
There were also some potential limitations with our study.
Exercise was self-reported, which may not be sensitive
enough. Objective measurements of exercise would be more
accurate than self-report questionnaires. However, the use of
devices such as accelerometers is not feasible in larger study
populations such as this one and may introduce bias. On the
other hand, the LTPA questionnaire has previously been used
successfully in large settings [10]. Furthermore, potential
changes in LTPA could not be estimated, since LTPAwas only
assessed at baseline. Work-related physical activity was not
assessed, leading to a potential underestimation of total phys-
ical activity. Other potential confounders such as nutrition or
socioeconomic status were not addressed, which may have
influenced the results.
In conclusion, this is one of the few prospective studies to
assess the relationship between physical activity and incident
CVD in patients with type 1 diabetes. The results suggest that
exercise, in particular a high frequency and high intensity
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exercise, may reduce the risk of CVD events. Further studies
are needed to describe the mechanisms responsible for this
effect and to evaluate all potential benefits and drawbacks of
frequent or intensive exercise in patients with type 1 diabetes.
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